Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.7275 EUR -1.09%
Market Cap: 493.5m EUR
Have any thoughts about
Pharming Group NV?
Write Note

Pharming Group NV
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharming Group NV
Capital Expenditures Peer Comparison

Comparables:
PRQR
QURE
ARGX
MRUS
LVTX

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Pharming Group NV
AEX:PHARM
Capital Expenditures
-$991k
CAGR 3-Years
60%
CAGR 5-Years
46%
CAGR 10-Years
-7%
ProQR Therapeutics NV
NASDAQ:PRQR
Capital Expenditures
-€1.9m
CAGR 3-Years
-62%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Capital Expenditures
-$5.4m
CAGR 3-Years
31%
CAGR 5-Years
0%
CAGR 10-Years
14%
argenx SE
XBRU:ARGX
Capital Expenditures
-$65.6m
CAGR 3-Years
20%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Capital Expenditures
-$1.8m
CAGR 3-Years
-22%
CAGR 5-Years
20%
CAGR 10-Years
N/A
LAVA Therapeutics NV
NASDAQ:LVTX
Capital Expenditures
-$730k
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharming Group NV's Capital Expenditures?
Capital Expenditures
-991k USD

Based on the financial report for Sep 30, 2024, Pharming Group NV's Capital Expenditures amounts to -991k USD.

What is Pharming Group NV's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-7%

Over the last year, the Capital Expenditures growth was 32%. The average annual Capital Expenditures growth rates for Pharming Group NV have been 60% over the past three years , 46% over the past five years , and -7% over the past ten years .

Back to Top